Volume 32, Issue 8 (November 2021)                   Studies in Medical Sciences 2021, 32(8): 581-588 | Back to browse issues page

Ethics code: IR.TBZMED.REC. 1399.255


XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Gozali P, Zeinalzadeh N, Khalaj Kondari M, Ardalan M R, Farzami kia N. EVALUATION OF THE ASSOCIATION OF MICA RS1051792 POLYMORPHISM AND CYTOMEGALOVIRUS INFECTION IN KIDNEY TRANSPLANT RECIPIENTS. Studies in Medical Sciences 2021; 32 (8) :581-588
URL: http://umj.umsu.ac.ir/article-1-5632-en.html
Assistant Professor of Molecular Genetics, University of Tabriz, Tabriz, Iran. (Corresponding Author) , nzeinalzadeh@gmail.com
Abstract:   (2269 Views)
Background & Aims: Cytomegalovirus (CMV) infection is one of the most prevalent infections among kidney transplant recipients. Due to the use of immunosuppressive medications in kidney transplant recipients, their immune system is low and complications of CMV infection such as transplant rejection are observed in them. The MICA gene encodes a stress-related protein that is involved in responding to the virus in virus-infected cells and cancer. One of the single nucleotide polymorphisms of the MICA gene is rs1051792. This polymorphism leads to a non-synonymous mutation which classifies the MICA alleles into strong (MICA-129 Met) and weak (MICA-129 Val) binders of the NKG2D receptor. The purpose of this study was to evaluate the association between MICA rs1051792 polymorphism and susceptibility to cytomegalovirus infection in kidney transplant recipients in the northwest of Iran.
Materials & Methods: This study included 51 cytomegalovirus-infected kidney transplant recipients as cases and 50 kidney transplant recipients without cytomegalovirus infection as control subjects. Genotyping was performed by PCR-RFLP technique.
Results: The percentage of frequencies of the genotypes AA, AG, GG was 17.64%, 45.09%, and 37.25% in the cases and 16%, 48%, and 36% in the control group, respectively. The statistical analysis did not indicate significant differences between the case and control groups (p>0.05).
Conclusion: The results do not support the association between MICA rs1051792 and susceptibility to cytomegalovirus infection in kidney transplant recipients. Findings emphasize the need to evaluate other candidates of the genetic polymorphisms in the study population.
Full-Text [PDF 573 kb]   (676 Downloads)    
Type of Study: Research | Subject: ژنتیک

References
1. Freeman RB Jr. The 'indirect' effects of cytomegalovirus infection. Am J Transplant 2009;9(11):2453-8 [DOI:10.1111/j.1600-6143.2009.02824.x] [PMID]
2. Van der Bij W, Speich R. Management of cytomegalovirus infection and disease after solid-organ transplantation. Clin Infect Dis 2001;33 Suppl 1:S32-S37. [DOI:10.1086/320902] [PMID]
3. De Keyzer K, Van Laecke S, Peeters P, Vanholder R. Human cytomegalovirus and kidney transplantation: a clinician's update. Am J Kidney Dis 2011;58(1):118-26. [DOI:10.1053/j.ajkd.2011.04.010] [PMID]
4. Humar A, Snydman D. AST Infectious Diseases Community of Practice. Cytomegalovirus in solid organ transplant recipients. Am J Transplant 2009;9 Suppl 4:S78-S86. [DOI:10.1111/j.1600-6143.2009.02897.x] [PMID]
5. Saeed B. Pediatric renal transplantation. Int J Organ Transplant Med 2012;3(2):62-73. [PMID] [PMCID]
6. Opelz G, Döhler B. Reduced rate of cardiovascular death after cytomegalovirus prophylaxis in renal transplant recipients. Transplantation 2015;99(6):1197-1202. [DOI:10.1097/TP.0000000000000522] [PMID]
7. Baranwal AK, Mehra NK. Major Histocompatibility Complex Class I Chain-Related A (MICA) Molecules: Relevance in Solid Organ Transplantation. Front Immunol 2017;8:182. [DOI:10.3389/fimmu.2017.00182]
8. Risti M, Bicalho MD. MICA and NKG2D: Is There an Impact on Kidney Transplant Outcome? Front Immunol 2017;8:179. [DOI:10.3389/fimmu.2017.00179] [PMID] [PMCID]
9. Luo L, Lu J, Wei L, Long D, Guo JY, Shan J, et al. The role of HIF-1 in up-regulating MICA expression on human renal proximal tubular epithelial cells during hypoxia/reoxygenation. BMC Cell Biol 2010;11:91. [DOI:10.1186/1471-2121-11-91] [PMID] [PMCID]
10. Tong HV, Toan NL, Song LH, Bock CT, Kremsner PG, Velavan TP. Hepatitis B virus-induced hepatocellular carcinoma: functional roles of MICA variants. J Viral Hepat 2013;20(10):687-98. [DOI:10.1111/jvh.12089] [PMID]
11. González S, Groh V, Spies T. Immunobiology of human NKG2D and its ligands. Curr Top Microbiol Immunol 2006;298:121-38. [DOI:10.1007/3-540-27743-9_6] [PMID]
12. Seidel E, Le VT, Bar-On Y, Tsukerman P, Enk J, Yamin R, et al. Dynamic Co-evolution of Host and Pathogen: HCMV Downregulates the Prevalent Allele MICA∗008 to Escape Elimination by NK Cells. Cell Rep 2015;10(6):968-82. [DOI:10.1016/j.celrep.2015.01.029] [PMID] [PMCID]
13. Raache R, Belanteur K, Amroun H, Benyahia A, Heniche A, Azzouz M, et al. Association of major histocompatibility complex class 1 chain-related gene a dimorphism with type 1 diabetes and latent autoimmune diabetes in adults in the Algerian population. Clin Vaccine Immunol 2012;19(4):557-61. [DOI:10.1128/CVI.05473-11] [PMID] [PMCID]
14. Choy MK, Phipps ME. MICA polymorphism: biology and importance in immunity and disease. Trends Mol Med 2010;16(3):97-106. [DOI:10.1016/j.molmed.2010.01.002] [PMID]
15. Wang Q, Zhou X. Associations of MICA Polymorphisms with Inflammatory Rheumatic Diseases. Open Rheumatol J 2015;9:94-100. [DOI:10.2174/1874312901409010094] [PMID] [PMCID]
16. Steinle A, Li P, Morris DL, Groh V, Lanier LL, Strong RK, et al. Interactions of human NKG2D with its ligands MICA, MICB, and homologs of the mouse RAE-1 protein family. Immunogenetics 2001;53(4):279-87. [DOI:10.1007/s002510100325] [PMID]
17. Stastny P. Introduction: MICA/MICB in innate immunity, adaptive immunity, autoimmunity, cancer, and in the immune response to transplants. Hum Immunol 2006;67(3):141-4. [DOI:10.1016/j.humimm.2006.02.019] [PMID]
18. Isernhagen A, Malzahn D, Bickeböller H, Dressel R. Impact of the MICA-129Met/Val Dimorphism on NKG2D-Mediated Biological Functions and Disease Risks. Front Immunol 2016;7:588. [DOI:10.3389/fimmu.2016.00588] [PMID] [PMCID]
19. López-Oliva MO, Flores J, Madero R, Escuin F, Santana MJ, Bellón T, et al. Cytomegalovirus infection after kidney transplantation and long-term graft loss. La infección por citomegalovirus postrasplante renal y pérdida del injerto a largo plazo. Nefrologia 2017;37(5):515-25. [DOI:10.1016/j.nefro.2016.11.018] [PMID]
20. Morran MP, Omenn GS, Pietropaolo M. Immunology and genetics of type 1 diabetes. Mt Sinai J Med 2008;75(4):314-27. [DOI:10.1002/msj.20052] [PMID]
21. Michita RT, Chies JA, Schramm S, Horn PA, Heinemann FM, Wunsch A, et al. A Valine Mismatch at Position 129 of MICA Is an Independent Predictor of Cytomegalovirus Infection and Acute Kidney Rejection in Simultaneous Pancreas⁻Kidney Transplantation Recipients. Int J Mol Sci 2018;19(9):2618. [DOI:10.3390/ijms19092618] [PMID] [PMCID]
22. Amroun H, Djoudi H, Busson M, Allat R, El Sherbini SM, Sloma I, et al. Early-onset ankylosing spondylitis is associated with a functional MICA polymorphism. Hum Immunol 2005;66(10):1057-61. [DOI:10.1016/j.humimm.2005.09.004] [PMID]
23. López-Hernández R, Valdés M, Lucas D, Campillo JA, Martínez-Garcia P, Salama H, et al. Association analysis of MICA gene polymorphism and MICA-129 dimorphism with inflammatory bowel disease susceptibility in a Spanish population. Hum Immunol 2010;71(5):512-4. [DOI:10.1016/j.humimm.2010.02.003] [PMID]
24. Yoshida K, Komai K, Shiozawa K, Mashida A, Horiuchi T, Tanaka Y, et al. Role of the MICA polymorphism in systemic lupus erythematosus. Arthritis Rheum 2011;63(10):3058-66. [DOI:10.1002/art.30501] [PMID]
25. Douik H, Chaaben AB, Romdhane NA, Romdhane HB, Mamoghli T, Fortier C, et al. Association of MICA-129 polymorphism with nasopharyngeal cancer risk in a Tunisian population. Hum Immunol 2009;70(1):45-8. [DOI:10.1016/j.humimm.2008.10.008] [PMID]
26. Boukouaci W, Busson M, Peffault de Latour R, Rocha V, Suberbielle C, Bengoufa D, et al. MICA-129 genotype, soluble MICA, and anti-MICA antibodies as biomarkers of chronic graft-versus-host disease. Blood 2009;114(25):5216-24. [DOI:10.1182/blood-2009-04-217430] [PMID]
27. Zhao J, Jiang Y, Lei Y, Zou K, Wang C, Huang S, et al. Functional MICA-129 polymorphism and serum levels of soluble MICA are correlated with ulcerative colitis in Chinese patients. J Gastroenterol Hepatol 2011;26(3):593-8. [DOI:10.1111/j.1440-1746.2010.06524.x] [PMID]
28. Ouni N, Ben Chaaben A, Kablouti G, Lajnef M, Ayari F, Abaza H, et al. MICA-129Met/Val Polymorphism Is Associated with Early-Onset Breast Cancer Risk. Immunol Invest 2017;46(6):603-14. [DOI:10.1080/08820139.2017.1336175] [PMID]
29. Mariaselvam CM, Boukouaci W, Charron D, Krishnamoorthy R, Tamouza R, Misra DP, et al. Association of MICA-129 polymorphism and circulating soluble MICA level with rheumatoid arthritis in a south Indian Tamil population. Int J Rheum Dis 2018;21(3):656-63. [DOI:10.1111/1756-185X.13138] [PMID]

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | Studies in Medical Sciences

Designed & Developed by : Yektaweb